Literature DB >> 15211572

Differential activation of ERK1,2 MAP kinase signaling pathway in mesenchymal stem cell from control and osteoporotic postmenopausal women.

J Pablo Rodríguez1, Susana Ríos, Mireya Fernández, J Francisco Santibañez.   

Abstract

Osteoblasts, the cells responsible for bone formation, derive from mesenchymal stem cells (MSCs) in bone marrow. To acquire a new cell phenotype, uncommitted MSCs must undergo several proliferation and differentiation changes. Although, it is known that extracellular signal-regulated protein kinases (ERKs) mitogen-activated protein (MAP) kinase pathway signaling is involved in the proliferation and differentiation processes, the role of ERKs in osteogenic differentiation it is controversial, at present. In addition, the function that ERK could play in MSCs derived from osteoporotic patients it is not well documented. In this study, we analyze whether previously observed differences in the dynamic response of MSCs from normal and osteoporotic postmenopausal women can be explained by changes in the activation of this signal transduction pathway. Levels of ERK phosphorylation and their correlation with osteogenic differentiation were evaluated in cultures of MSCs derived from osteoporotic postmenopausal women and "healthy" controls. The results show that, under basal conditions, MSCs derived from osteoporotic donors show a level of ERK phosphorylation 2.5 times higher than MSCs derived from control donors. The addition of the osteogenic stimulus only slightly increases the p-ERK level in cells derived from osteoporotic donors, and is higher in cells derived from control women. Important differences in the ability of PD98059 to inhibit phosphorylation of ERK in both types of cells were also observed, as well as the effect that this inhibition produced on calcium deposition. We conclude that the MAP kinase pathway signaling is differentially activated in MSCs derived from osteoporotic postmenopausal women. The high p-ERK levels in MSC derived from osteoporotic donors could determine the unresponsiveness of these cells to the osteogenic differentiation stimulus. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15211572     DOI: 10.1002/jcb.20119

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  29 in total

1.  Estrogen deficiency does not decrease the in vitro osteogenic potential of rat adipose-derived mesenchymal stem cells.

Authors:  Francesca Veronesi; Stefania Pagani; Elena Della Bella; Gianluca Giavaresi; Milena Fini
Journal:  Age (Dordr)       Date:  2014-04-01

Review 2.  Application of stem cells in bone repair.

Authors:  Elaine Y L Waese; Rita A Kandel; Rita R Kandel; William L Stanford
Journal:  Skeletal Radiol       Date:  2008-01-12       Impact factor: 2.199

3.  CYR61 regulates BMP-2-dependent osteoblast differentiation through the {alpha}v{beta}3 integrin/integrin-linked kinase/ERK pathway.

Authors:  Jen-Liang Su; Jean Chiou; Chih-Hsin Tang; Ming Zhao; Chun-Hao Tsai; Pai-Sheng Chen; Yi-Wen Chang; Ming-Hsien Chien; Chu-Ying Peng; Michael Hsiao; Ming-Liang Kuo; Men-Luh Yen
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

4.  Catechin stimulates osteogenesis by enhancing PP2A activity in human mesenchymal stem cells.

Authors:  Y J Wei; K S Tsai; L C Lin; Y T Lee; C W Chi; M C Chang; T H Tsai; S C Hung
Journal:  Osteoporos Int       Date:  2010-08-04       Impact factor: 4.507

Review 5.  New insights into osteoporosis: the bone-fat connection.

Authors:  M Kawai; F J A de Paula; C J Rosen
Journal:  J Intern Med       Date:  2012-07-29       Impact factor: 8.989

6.  Human Periosteal Derived Stem Cell Potential: The Impact of age.

Authors:  Concetta Ferretti; Guendalina Lucarini; Chiara Andreoni; Eleonora Salvolini; Novella Bianchi; Giovanni Vozzi; Antonio Gigante; Monica Mattioli-Belmonte
Journal:  Stem Cell Rev Rep       Date:  2015-06       Impact factor: 5.739

7.  Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis.

Authors:  Nan Su; Qidi Sun; Can Li; Xiumin Lu; Huabing Qi; Siyu Chen; Jing Yang; Xiaolan Du; Ling Zhao; Qifen He; Min Jin; Yue Shen; Di Chen; Lin Chen
Journal:  Hum Mol Genet       Date:  2010-01-06       Impact factor: 6.150

8.  Implication of NOD1 and NOD2 for the differentiation of multipotent mesenchymal stem cells derived from human umbilical cord blood.

Authors:  Hyung-Sik Kim; Tae-Hoon Shin; Se-Ran Yang; Min-Soo Seo; Dong-Jae Kim; Soo-Kyung Kang; Jong-Hwan Park; Kyung-Sun Kang
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

Review 9.  Marrow fat and the bone microenvironment: developmental, functional, and pathological implications.

Authors:  Clifford J Rosen; Cheryl Ackert-Bicknell; Juan Pablo Rodriguez; Ana Maria Pino
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

10.  Gravity, a regulation factor in the differentiation of rat bone marrow mesenchymal stem cells.

Authors:  Yan Huang; Zhong-Quan Dai; Shu-Kuan Ling; Hong-Yu Zhang; Yu-Min Wan; Ying-Hui Li
Journal:  J Biomed Sci       Date:  2009-09-21       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.